EUVIMEDEUVIMED entdecken
Crossref

Machine Learning and Molecular Modeling Reveal HDAC6 as a Key Target of Tanshinone IIA in Multiple Myeloma

Jian Gao iD, Jiawen Chu, Pengpeng Li

The Journal of Physical Chemistry B · 2026

DOI: 10.1021/acs.jpcb.6c03788 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Physical Chemistry B, 2026. Verfasst von Jian Gao und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Anhui University of Science and Technology, Huainan232001, China. Hauptthemen laut MEDLINE: Histone Deacetylase 6, Multiple Myeloma, Abietanes, Machine Learning. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Natural Science Foundation of Anhui Province, Anhui University of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma (MM) is a malignant blood cancer marked by severe bone destruction and immune microenvironment disruption. Yet relapse and drug resistance remain major clinical challenges. Tanshinone IIA (TIIA) exhibits potent antitumor activity, but its molecular targets and mechanisms in MM remain unclear. Here, we systematically elucidate TIIA’s pharmacological mechanisms in MM using network pharmacology, transcriptomics, molecular docking, molecular dynamics (MD) simulations, and in vitro cellular experiments. Histone deacetylase 6 (HDAC6) was identified as a key prognostic target in MM via integrative bioinformatics─combining cross-database analysis, machine learning (LASSO, SVM-RFE, random forest), and survival validation in the MMRF-CoMMpass cohort. Molecular docking and MD simulations showed stable binding of TIIA to HDAC6. In vitro, TIIA directly inhibited HDAC6 enzymatic activity and selectively killed U266 and RPMI 8226 myeloma cells in a dose-dependent manner, with minimal toxicity to normal cells. Additionally, gene set enrichment analysis (GSEA) and single-sample GSEA (ssGSEA) immune profiling using the LM22 signature suggested that HDAC6 participates in microenvironmental remodeling by modulating cell adhesion-mediated resistance and orchestrating an immunosuppressive niche characterized by monocyte depletion. This study highlights for the first time the critical role of HDAC6 in TIIA-mediated antimyeloma activity and provides novel mechanistic insights and potential targeted therapeutic strategies for the treatment of MM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone Deacetylase 6Multiple MyelomaAbietanesMachine LearningHistone Deacetylase InhibitorsHumansMolecular Dynamics SimulationMolecular Docking SimulationCell Line, Tumor

Substanzen

Histone Deacetylase 6tanshinoneAbietanesHDAC6 protein, humanHistone Deacetylase Inhibitors

Autor:innen und Institutionen

  • School of Medicine, Anhui University of Science and Technology, Huainan232001, China.

ORCID-Profile: Jian Gao

Förderung

  • Natural Science Foundation of Anhui Province
  • Anhui University of Science and Technology

Zitieren

APA

Gao, J., Chu, J., & Li, P. (2026). Machine Learning and Molecular Modeling Reveal HDAC6 as a Key Target of Tanshinone IIA in Multiple Myeloma. The Journal of Physical Chemistry B. https://doi.org/10.1021/acs.jpcb.6c03788

Vancouver

Gao J, Chu J, Li P. Machine Learning and Molecular Modeling Reveal HDAC6 as a Key Target of Tanshinone IIA in Multiple Myeloma. The Journal of Physical Chemistry B. 2026. doi:10.1021/acs.jpcb.6c03788

BibTeX
@article{Gao2026,
  author = {Gao, Jian and Chu, Jiawen and Li, Pengpeng},
  title = {Machine Learning and Molecular Modeling Reveal HDAC6 as a Key Target of Tanshinone IIA in Multiple Myeloma},
  journal = {The Journal of Physical Chemistry B},
  year = {2026},
  doi = {10.1021/acs.jpcb.6c03788}
}
Kostenlos starten →